Skip to main content

Coverage Determination

The coverage determination process for prior authorization ensures that medication regimens that are high risk, have a high potential for misuse, or narrow therapeutic indices are used appropriately and according to FDA-approved indications.

The coverage determination process is required for:

  • Duplication of therapy
  • Prescriptions that exceed the FDA daily or monthly quantity limit
  • Most self-injectable and infusion medications (including chemotherapy)
  • Drugs not listed on the PDL
  • Drugs that have an age edit
  • Drugs listed on the PDL but still require Prior Authorization (PA)
  • Brand name drugs when a generic exists
  • Drugs that have a step therapy edit and the first-line therapy is inappropriate

Need help? We're here for you.

Contact Us
Last Updated On: 12/4/2020
WellCare will be performing maintenance on Saturday, September 25, 2021 at 6pm EST until Sunday, September 26, 2021 at 6am EST. You might not be able to access systems or fax during this time. We are sorry for any issues this may cause. Thank you for your patience. If you need assistance, contact us. ×